You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Novel Catalyst Systems
SBC: COMPACT MEMBRANE SYSTEMS, INC. Topic: NIGMSDESCRIPTION (provided by applicant): Transition metal catalysts are widely used in the pharmaceutical industry for the production of active ingredients, precursors and new drug candidates. These products must be very pure, often requiring labor and energyintensive separation processes, to achieve the required purity levels. Of special concern in the present context is to avoid contaminating the pr ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Customized Nanofiltration Membranes for Enhancing Pharmaceutical Manufacturing
SBC: COMPACT MEMBRANE SYSTEMS, INC. Topic: NIGMSDESCRIPTION (provided by applicant): The overall focus of this application is to develop nanofiltration membranes to recover the spent solvents generated from drug manufacturing processes allowing the solvents to be reused resulting in elimination of waste. This is also responsive to NIH RFP PA-09-100 entitled Energy Efficiency and Renewable Energy System Technology Research and Development . By ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Novel Materials and Methods for Separations of Glycopeptides and Glycans
SBC: ADVANCED MATERIALS TECHNOLOGY, INC. Topic: NIGMSDESCRIPTION (provided by applicant): Analysis of glycoprotein polypeptide sites of carbohydrate attachment and the structures of the glycans present on these proteins requires the combination of high resolution chromatographic separations and sophisticatedmass spectrometry. Hydrophilic interaction liquid chromatography (HILIC) has great use in separations of glycopeptides and released glycans, exh ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Smaller Particle Fused-Core Silicas for Higher Performance Separations
SBC: ADVANCED MATERIALS TECHNOLOGY, INC. Topic: NIGMSDESCRIPTION (provided by applicant): Life sciences research and other critical bioanalytical applications would strongly benefit from faster and higher resolution liquid chromatographic (HPLC) separations for both small molecules and larger molecules suchas proteins, peptides, glycopeptides, and glycans. Many HPLC separations of biomedical interest, such as proteomic or glycomic profiling, require ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Novel Nanofiltration Membranes for Isolation of Pharmaceutical Compounds
SBC: COMPACT MEMBRANE SYSTEMS, INC. Topic: NCRRDESCRIPTION (provided by applicant): Novel Nanofiltration Membranes for Isolation of Pharmaceutical Compounds Project Summary: In the chemical manufacturing of pharmaceutical compounds, organic syntheses are often carried out in organic solvents and involve intermediates and final products with high added value. These pharmaceutical active compounds having molecular weights in the range of 300-200 ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Low Light Level Camera For Raman Spectroscopy
SBC: B & W TEK INC Topic: NCRRDESCRIPTION (provided by applicant): Raman spectroscopy is a potentially important clinical tool for real-time diagnosis of diseases and in situ evaluation of living tissues. However, the application of Raman spectroscopy for tissue evaluation has been limited by the strong tissue fluorescence that often overwhelms the extremely weak Raman signal. The goal of this proposal is to develop an infrare ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Enhanced Fluoropolymer Membrane Reactors for Production of Pharmaceutical Interme
SBC: COMPACT MEMBRANE SYSTEMS, INC. Topic: NCRRDESCRIPTION (provided by applicant): The commercial syntheses of many pharmaceutical active ingredients and intermediates require acid catalysts and the removal of water to drive reactions to completion. Typical reactions include esterifications of carboxylic acids with alcohols, Friedel-Crafts acylations and alkylations, Schiff base, acetal and ketal formation and nitrations of aromatic compounds ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Phased array three-dimensional beam steering system for millimeter wave sources emitting in the 100-300 GHz region
SBC: PHASE SENSITIVE INNOVATIONS INC Topic: A11006Herein, we propose a novel approach to achieving a broadband, phased-array transmitter operating at frequencies from 100-300 GHz. Our approach is based on the concept of optically distributing a pair of locked optical tones to an array of antenna coupled photomixers. Lightweight optical fibers enable the distribution of these optical tones to any arbitrary antenna array geometry with antenna pla ...
SBIR Phase I 2011 Department of DefenseArmy -
A Novel, Nanostructured, Metal-organic Frameworks-Based Product Loss Prevention Technology in the Oil and Natural Gas Sector
SBC: FRAMERGY INC Topic: 17NCER2CTo reach the end user, oil and gas production at the wellhead must be transmitted through the country and distributed to a wide range of customers. This logistical system requires natural gas gathering lines, processing facilities, product storage tanks and lots of other equipment. What results is air pollution caused by industry losses during these operations and the use of continuous or intermit ...
SBIR Phase I 2018 Environmental Protection Agency -
A High-Throughput, Multi-Omic Assay of Tumor Biomarkers from Single-Cells
SBC: ISOPLEXIS CORPORATION Topic: 172SUMMARY Although solid tumors oftentimes arise from the uninhibited growth of a single aberrant cellthe population of cells within a tumor are genetically and molecularly heterogenousThis makes it very difficult to evaluate a therapy s efficacy when using bulk population measurementsFurthermorerecent research has implicated microRNAsmiRNAsas drivers of progression and malignancy in many tumor type ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health